Classify Rx for pharmacology
43
Quality Score
Emerging
Classify Rx for pharmacology
Low confidence
✍️ bumetric analysis
“
Classify Rx for pharmacology is an iOS app from Nishith Sekhar Revappala in the Education category, currently rated 3.7★ across 11 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 43: Emerging (early traction worth watching). For a Education app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
→
12-mo forecast
$5.2K – $10.8K
per month
→
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🤖Also on Android
$376/mo · 724 ratings · 3.9★
View →
ONE-TIME · BUILD
💰 Estimated build cost
$95K
↳ What it cost to build · not monthly revenue
Likely range $70K – $130K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (126 MB) | +$30K |
| ⚙ Education complexity ×1.20 | +$16K |
Total estimate
$95K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$15K
↳ What it would sell for · not monthly revenue
Marketplace range $10K – $15K · 14× MRR multiple
💸
~0.2× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating 3.5-4.0 (mixed) | -8% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
14× MRR
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 44/100MID TIERunderperforming peersRevenue Strength
3.7
Product Quality
3.0
Market Position
2.0
Growth Velocity
5.0
Defensibility
5.8
Operational Safety
10.0
Founder Strength
4.9
Monetization Maturity
1.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 3.73★ across 11 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (11 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v5.0.1
Minor bug fixes
Content update
Content update
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Classify Rx for pharmacology
- Developer
- Nishith Sekhar Revappala
- Bundle ID
- com.scoopmed.Classify
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $976/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth11 ratings+1000% lifetimeShow 3-year history estimate ▾
Tracked (10 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
A must have app for all medical and paramedical students.
"Hands down the best app for simple, quick and concise review of real Pharmacology"
Dr. Aeloj Shrestha
"Brilliant and must have app for medical students"
Sadat Mudassir
"Perfect Revision App"
Dhruvish Kapadia
“Drugs are the cornerstone of modern therapeutics”
-Harrison’s Principles of Internal Medicine
Pharmacology is the most important subject for building a strong career in modern healthcare. Pharmacology is one of the most difficult subject to go through in medical as well as other paramedical fields.… View full description on the official store →
"Hands down the best app for simple, quick and concise review of real Pharmacology"
Dr. Aeloj Shrestha
"Brilliant and must have app for medical students"
Sadat Mudassir
"Perfect Revision App"
Dhruvish Kapadia
“Drugs are the cornerstone of modern therapeutics”
-Harrison’s Principles of Internal Medicine
Pharmacology is the most important subject for building a strong career in modern healthcare. Pharmacology is one of the most difficult subject to go through in medical as well as other paramedical fields.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 126 MB🔞 17+📱 iOS 17.0+🔖 v5.0.1🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
6 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-03
⭐
Rating ↑ 3.78 → 5.00 (improved 1.22★)
2026-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2018-09
⭐
Rating ↑ 2.75 → 3.20 (improved 0.45★)
2017-09
⭐
Rating ↓ 3.33 → 2.75 (dropped 0.58★)
2017-07
⭐
Rating ↓ 4.00 → 3.33 (dropped 0.67★)
2017-02
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇺🇸 US | 3.72727★ | 11 | 3.72727★ this version |
| 🇬🇧 GB | 3★ | 3 | 3★ this version |
| 🇩🇪 DE | 5★ | 1 | 5★ this version |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇨🇦 CA | 3★ | 1 | 3★ this version |
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 5★ | 1 | 5★ this version |
| 🇮🇳 IN | 4.42856★ | 7 | 4.42856★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by Nishith Sekhar Revappala
View all →📦 Portfolio summaryINDIE studio
3apps·$1K/mocombined
Lead-app heavy — top app contributes 68%
About this analysis
Why low confidence: only 11 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Classify Rx for pharmacology is a early-stage iOS app in the education space with weak public traction — only 11 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Classify Rx for pharmacology make per month?▴
Our model estimates Classify Rx for pharmacology earns roughly $975/mo, but with only 11 ratings the confidence interval is wide. No founder-verified MRR is available for this app, so this is a model output calibrated against comparable apps in the same category. See methodology for the formula.
What apps are like Classify Rx for pharmacology?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Classify Rx for pharmacology?▴
Classify Rx for pharmacology is published by Nishith Sekhar Revappala on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Classify Rx for pharmacology's BU Score?▴
Classify Rx for pharmacology has a BU Score of 43/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.